Home Carboxes 1803583-09-6
1803583-09-6,MFCD28139347
Catalog No.:AA00ALZ7

1803583-09-6 | Methyl 6-chloro-5-nitropicolinate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$6.00   $4.00
- +
250mg
95%
in stock  
$7.00   $5.00
- +
1g
95%
in stock  
$12.00   $8.00
- +
5g
95%
in stock  
$36.00   $26.00
- +
10g
95%
in stock  
$61.00   $43.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00ALZ7
Chemical Name:
Methyl 6-chloro-5-nitropicolinate
CAS Number:
1803583-09-6
Molecular Formula:
C7H5ClN2O4
Molecular Weight:
216.5786
MDL Number:
MFCD28139347
SMILES:
COC(=O)c1ccc(c(n1)Cl)[N+](=O)[O-]
Properties
Computed Properties
 
Complexity:
242  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
2  
XLogP3:
1.8  

Downstream Synthesis Route
56057-19-3   
methyl6-chloro-5-nitropyridine-2-carboxylate 

[1]Patent:US2018/170908,2018,A1

67-56-1    353277-27-7   
methyl6-chloro-5-nitropyridine-2-carboxylate 

[1]Patent:US2018/170908,2018,A1.Locationinpatent:Paragraph0430

[1]CurrentPatentAssignee:QILUREGORTHERAPEUTICS-WO2020/207474,2020,A1Locationinpatent:Page/Pagecolumn59;70;71

[2]CurrentPatentAssignee:ILDONGPHARMACEUTICALCO.,LTD.-WO2021/96304,2021,A1Locationinpatent:Paragraph212;295-299

[3]CurrentPatentAssignee:GUANGZHOUBEBETTERMEDICINETECH-CN113480534,2021,ALocationinpatent:Paragraph0094;0119;0126

[4]CurrentPatentAssignee:PFIZERINC-US2018/170908,2018,A1Locationinpatent:Paragraph0431

[5]CurrentPatentAssignee:PFIZERINC-WO2019/239371,2019,A1Locationinpatent:Page/Pagecolumn84

[6]CurrentPatentAssignee:HUADONGMEDICINECO.,LTD.-WO2022/78152,2022,A1Locationinpatent:Page/Pagecolumn39

[7]CurrentPatentAssignee:SERVIERMONDE-WO2022/184849,2022,A1Locationinpatent:Page/Pagecolumn88-90

[8]CurrentPatentAssignee:SERVIERMONDE-WO2022/184849,2022,A1Locationinpatent:Page/Pagecolumn88-90

[9]CurrentPatentAssignee:HUADONGMEDICINECO.,LTD.-WO2022/199458,2022,A1Locationinpatent:Page/Pagecolumn28

[1]CurrentPatentAssignee:PFIZERINC-US2018/170908,2018,A1

[2]CurrentPatentAssignee:QILUREGORTHERAPEUTICS-WO2020/207474,2020,A1

[3]CurrentPatentAssignee:ILDONGPHARMACEUTICALCO.,LTD.-WO2021/96304,2021,A1

[4]CurrentPatentAssignee:GUANGZHOUBEBETTERMEDICINETECH-CN113480534,2021,A

[5]CurrentPatentAssignee:SERVIERMONDE-WO2022/184849,2022,A1

[1]CurrentPatentAssignee:PFIZERINC-US2018/170908,2018,A1

[2]CurrentPatentAssignee:ILDONGPHARMACEUTICALCO.,LTD.-WO2021/96304,2021,A1

[3]CurrentPatentAssignee:GUANGZHOUBEBETTERMEDICINETECH-CN113480534,2021,A

[4]CurrentPatentAssignee:SERVIERMONDE-WO2022/184849,2022,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1803583-09-6 Molecular Formula|1803583-09-6 MDL|1803583-09-6 SMILES|1803583-09-6 Methyl 6-chloro-5-nitropicolinate |Heterocyclic_Building_Blocks